[{"data":1,"prerenderedAt":174},["ShallowReactive",2],{"drug-vilazodone":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":20,"regimens":51,"contraindications":75,"warnings":85,"renal":100,"monitoring":101,"interactions":102,"review":103,"examples":106,"atc":111,"iran":113,"usApproval":125,"links":131,"populations":148},"vilazodone",1,{"fa":7,"en":8},"ویلازودون","Vilazodone","nervous-system",{"fa":11,"en":12},"ضدافسردگی (SSRI + آگونیست نسبی 5-HT1A)","Antidepressant (SSRI + 5-HT1A partial agonist)",[14],{"name":15,"market":16},"Viibryd","US",[18,19,7],"viibryd","ویبرید",[21,35,43],{"id":22,"form":23,"route":24,"label":25,"concentration":26,"markets":30,"refs":31},"tab-20","tablet","oral","20 mg tablet",{"amount":27,"unit":28,"perUnit":23,"scored":29},20,"mg",false,[16],[32],{"source":33,"section":34},"fda-viibryd","3",{"id":36,"form":23,"route":24,"label":37,"concentration":38,"markets":40,"refs":41},"tab-40","40 mg tablet",{"amount":39,"unit":28,"perUnit":23,"scored":29},40,[16],[42],{"source":33,"section":34},{"id":44,"form":23,"route":24,"label":45,"concentration":46,"markets":48,"refs":49},"tab-10","10 mg tablet",{"amount":47,"unit":28,"perUnit":23,"scored":29},10,[16],[50],{"source":33,"section":34},[52],{"id":53,"disease":53,"label":54,"population":57,"type":61,"unit":28,"dose":62,"refs":63,"notes":66},"mdd",{"fa":55,"en":56},"افسردگی اساسی بزرگسال — هدف ۲۰ تا ۴۰ mg یک بار با غذا","Major depressive disorder, adults — target 20–40 mg once daily with food",{"minAge":58},{"value":59,"unit":60},18,"year","fixed",{"perDose":27,"perDoseMax":39,"dosesPerDay":5},[64],{"source":33,"section":65},"2.1",[67],{"text":68,"refs":71},{"fa":69,"en":70},"شروع ۱۰ mg ۷ روز، سپس ۲۰ mg؛ پس از دست‌کم ۷ روز تا ۴۰ mg. پیش از شروع اختلال دوقطبی بررسی شود. قطع تدریجی.","Start 10 mg for 7 days, then 20 mg; after ≥7 days up to 40 mg. Screen for bipolar disorder first. Taper when stopping.",[72,73],{"source":33,"section":65},{"source":33,"section":74},"2.2",[76],{"id":77,"severity":78,"text":79,"refs":82},"maoi","block",{"fa":80,"en":81},"مهارکننده MAO همزمان، ظرف ۱۴ روز پس از قطع آن، یا ظرف 14 روز پس از قطع این دارو؛ لینزولید یا متیلن بلو وریدی (سندرم سروتونین).","MAOIs concomitantly, within 14 days of stopping them, or within 14 days of stopping this drug; linezolid or IV methylene blue (serotonin syndrome).",[83],{"source":33,"section":84},"4",[86,93],{"text":87,"refs":90},{"fa":88,"en":89},"هشدار جعبه‌ای: افزایش افکار و رفتار خودکشی در کودکان و جوانان — پایش بدتر شدن بالینی.","Boxed warning: increased suicidal thoughts and behaviours in children and young adults — monitor for clinical worsening.",[91],{"source":33,"section":92},"Boxed Warning",{"text":94,"refs":97},{"fa":95,"en":96},"سندرم سروتونین؛ تشنج؛ اختلال عملکرد جنسی.","Serotonin syndrome; seizures; sexual dysfunction.",[98],{"source":33,"section":99},"5",[],[],[],{"status":104,"reviewer":105,"date":105},"unverified",null,[107],{"regimen":53,"formulation":22,"input":108,"expect":110},{"ageYears":39,"weightKg":109},70,{"perDose":27,"tabletsPerDoseRounded":5,"upperPerDose":39},[112],"N06AX24",{"status":114,"forms":115,"refs":120},"registered",[116],{"code":117,"en":118,"fa":119},"19933","VILAZODONE 20MG TAB","قرص ویلازودون ۲۰ میلی‌گرم",[121],{"source":122,"section":123,"url":124},"darooyab-generic","G-4709\u002FVILAZODONE","https:\u002F\u002Fwww.darooyab.ir\u002FG-4709\u002FVILAZODONE",{"kind":126,"refs":127,"id":130},"NDA",[128],{"source":33,"section":129},"SPL approval \u002F marketing category","NDA022567",[132,135,139,142,145],{"kind":133,"url":134,"label":130},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=022567",{"kind":136,"url":137,"label":138},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=4c55ccfb-c4cf-11df-851a-0800200c9a66","FDA Viibryd",{"kind":140,"url":141,"label":8},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa611020.html",{"kind":143,"url":144,"label":112},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=N06AX24",{"kind":146,"url":124,"label":147},"darooyab","VILAZODONE",{"pregnancy":149,"pediatric":158,"geriatric":166},{"level":150,"text":151,"quote":154,"refs":155},"caution",{"fa":152,"en":153},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Risk Summary Based on data from published observational studies, exposure to SSRIs, particularly in the month before delivery, has been associated with a less than 2-fold increase in the risk of postpartum hemorrhage [see Warnings and Precautions ( 5.3 ) and Clinical Considerations] .",[156],{"source":33,"section":157},"8.1",{"level":159,"text":160,"quote":163,"refs":164},"avoid",{"fa":161,"en":162},"هشدار جعبه‌ای برچسب درباره کودکان.","Boxed warning in the label about children.","Antidepressants increased the risk of suicidal thoughts and behavi ors in pediatric and young adult patients in short-term studies.",[165],{"source":33,"section":92},{"level":150,"text":167,"quote":170,"refs":171},{"fa":168,"en":169},"برچسب: در سالمندان با احتیاط و معمولاً از دوز پایین شروع شود.","Label: use with caution in older adults, usually starting at the low end of the dose range.","Serotonergic antidepressants have been associated with cases of clinically significant hyponatremia in elderly patients, who may be at greater risk for this adverse reaction [see Warnings and Precautions ( 5.8 )] .",[172],{"source":33,"section":173},"8.5",1792191572656]